Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
💎 Access the Market Tools Trusted by Thousands of Investors Get Started
Ackman calls out Icahn's IEP over high premium after Hindenburg report
Published May 24, 2023 06:35PM ET
Updated May 24, 2023 06:41PM ET
© Reuters. FILE PHOTO: Bill Ackman, chief executive officer and portfolio manager at Pershing Square Capital Management, speaks during the SALT conference in Las Vegas, Nevada, U.S. May 18, 2017. REUTERS/Richard Brian
(Reuters) - Bill Ackman questioned the valuation of Carl Icahn's flagship firm as he took another jab at his old rival, whose company has become the target of short-seller Hindenburg Research.
The billionaire investor said in a tweet on Wednesday that he was "fascinated" by the situation between the short seller and Icahn Enterprises, while noting that the company's premium had been sustained by a large dividend yield.
"The yield is generated by returning capital to outside shareholders, which is in turn funded by the company selling stock to investors," Ackman said, adding the system is highly dependent on the "maintenance of the premium and the placidity of Icahn's margin lender(s)".
A representative for Icahn was not immediately available for comment. Bill Ackman declined to comment beyond his tweet.
In its report, Hindenburg has accused IEP of overvaluing its holdings and relying on a "Ponzi-like" structure to pay dividends. Icahn has called Hindenburg's report "self-serving" and reiterated his defense of the company.
Shares in IEP have lost more than half their value so far this year. The stock was down another 0.3% in extended trading.
On May 10, IEP said it was contacted by U.S. prosecutors, and it posted a surprise quarterly loss in the first quarter.
Icahn locked horns with Ackman over the supplement company Herbalife (NYSE:HLF) in early 2013 by taking the opposite side of the trade, in what was dubbed at the time as "the battle of the billionaires".
"IEP's performance history and governance structure do not justify a premium; rather they suggest that a large discount to net asset value would be appropriate," Ackman said, adding he was neither long nor short on the stock.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.